NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit

0
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit

NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit

NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit

PR Newswire

SAN DIEGO, Oct. 14, 2025

SAN DIEGO, Oct. 14, 2025 /PRNewswire/ — The Shareholders Foundation, Inc. announces that an update in the lawsuit that is currently pending for certain investors in Elevance Health, Inc. (NYSE: ELV) shares.

Investors who purchased shares of Elevance Health, Inc. (NYSE: ELV) prior to April 2024 and continue to hold any of those NYSE: ELV shares have also certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – 1554.

On March 12, 2025 an investor in NYSE: ELV shares over alleged securities laws violations by Elevance Health, Inc. The plaintiff alleged that the defendants represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs, that in fact, sicker patients with higher acuity tended to remain on Medicaid after redetermination, leading to higher per-patient costs, that this increase in cost was occurring at a rate that was not adequately reflected in Elevance’s rate negotiations with the states or in its financial guidance for 2024, and that as a result, the Complaint alleges Defendants’ positive statements concerning Elevance’s close monitoring of the redeterminations, the actuarial soundness of its rates and the prudence of its forecasts were materially misleading and/or lacked a reasonable basis.

On October 07, 2025, an amended complaint was filed.

Those who purchased shares of Elevance Health, Inc. (NYSE: ELV) should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholders Foundation, Inc. 
Michael Daniels 
+1 (858) 779-1554 
[email protected] 
3111 Camino Del Rio North 
Suite 423 
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

View original content to download multimedia:

SOURCE Shareholders Foundation, Inc.


The articles, information, and content displayed on this webpage may
include materials prepared and provided by third parties. Such
third-party content is offered for informational purposes only and
is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the
accuracy, completeness, timeliness, or reliability of any third-party
content displayed on this site. The views and opinions expressed in
third-party content are those of the respective authors and do not
necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays
in this content, nor for any actions taken in reliance thereon.
Users are advised to exercise their own judgment and seek independent
financial advice before making any decisions based on such content.
The third-party providers of this content are not affiliated with
Morningstar, and their inclusion on this site does not imply any
form of partnership, agency, or endorsement.

link

Leave a Reply

Your email address will not be published. Required fields are marked *